Translational neuroscience : toward new therapies / edited by Karoly Nikolich and Steven E. Hyman ; Program Advisory Committee, Steven E. Hyman, Julia Lupp, Robert C. Malenka, Karoly Nikolich, Menelas N. Pangalos, and Bernd Sommer.
2015
RC337 .T729 2015eb
Linked e-resources
Linked Resource
Online Access through The MIT Press Direct
Details
Title
Translational neuroscience : toward new therapies / edited by Karoly Nikolich and Steven E. Hyman ; Program Advisory Committee, Steven E. Hyman, Julia Lupp, Robert C. Malenka, Karoly Nikolich, Menelas N. Pangalos, and Bernd Sommer.
ISBN
9780262329859 (electronic bk.)
0262329859 (electronic bk.)
0262029863
9780262029865
9780262329866 (ebk)
0262329867
0262329859 (electronic bk.)
0262029863
9780262029865
9780262329866 (ebk)
0262329867
Published
Cambridge, MA : The MIT Press, [2015]
Language
English
Description
1 online resource : illustrations.
Call Number
RC337 .T729 2015eb
Dewey Decimal Classification
616.80072
Summary
Today, translational neuroscience faces significant challenges. Available therapies to treat brain and nervous system disorders are extremely limited and dated, and further development has effectively ceased. Disinvestment by the private sector occurred just as promising new technologies in genomics, stem cell biology, and neuroscience emerged to offer new possibilities. In this volume, experts from both academia and industry discuss how novel technologies and reworked translation concepts can create a more effective translational neuroscience. The contributors consider such topics as using genomics and neuroscience for better diagnostics and biomarker identification; new approaches to disease based on stem cell technology and more careful use of animal models; and greater attention to human biology and what it will take to make new therapies available for clinical use.
Note
Today, translational neuroscience faces significant challenges. Available therapies to treat brain and nervous system disorders are extremely limited and dated, and further development has effectively ceased. Disinvestment by the private sector occurred just as promising new technologies in genomics, stem cell biology, and neuroscience emerged to offer new possibilities. In this volume, experts from both academia and industry discuss how novel technologies and reworked translation concepts can create a more effective translational neuroscience. The contributors consider such topics as using genomics and neuroscience for better diagnostics and biomarker identification; new approaches to disease based on stem cell technology and more careful use of animal models; and greater attention to human biology and what it will take to make new therapies available for clinical use.
Source of Description
OCLC-licensed vendor bibliographic record.
Added Author
Nikolich, Karoly.
Hyman, Steven E.
Hyman, Steven E.
Record Appears in
Online Resources > Ebooks
All Resources
All Resources